This quasi-experimental study evaluates whether a low-technology, pharmacist-inclusive Short Message Service (SMS) notification of final blood culture results improves the timeliness and appropriateness of antimicrobial therapy in a resource-limited tertiary care setting.
HemoAlert speeds up appropriate antimicrobial therapy for bacteremia.
Timely initiation of appropriate antimicrobial therapy is crucial for improving outcomes in patients with bacteremia. The HemoAlert notification program reduced time to appropriate therapy and increased appropriate therapy within 72 hours by 34.0% vs 22.7% (P = .03). The study suggests that notification systems like HemoAlert can significantly improve antimicrobial management, although the impact on mortality was not significant. The HemoAlert program enhances the timing and appropriateness of therapy in bacteremia patients.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Phuetphaichit S, Samanloh S, Kamolvit W, Rattanaumpawan P
Citation:Phuetphaichit S, Samanloh S, Kamolvit W, et al. Impact of hemo-alert program on appropriate antimicrobial therapy in hospitalized patients with bacteremia: a quasi-experimental study. Antimicrobial stewardship & healthcare epidemiology : ASHE. 2026;6(1):e220. doi:10.1017/ash.2026.10757